Skip to main content
. Author manuscript; available in PMC: 2024 Jan 13.
Published in final edited form as: Alzheimers Dement. 2022 Jul 13;19(3):980–998. doi: 10.1002/alz.12714

Figure 3: Overlap across independent cohorts and brain regions.

Figure 3:

a, The Mayo and ROS/MAP cohorts have 30 metabolic associations with consistent effect directions in common. b, The BLSA and ROS/MAP cohorts have 5 metabolic associations with consistent effect directions in common (green and brown). Cysteine showed inconclusive effect directions, with a positive association with AD in the BLSA cohort and a negative association with AD traits in the ROS/MAP cohort.